Day: April 27, 2021

Intellia Therapeutics Announces Presentations at the 24th American Society of Gene and Cell Therapy Annual Meeting

Written by Customer Service on April 27, 2021. Posted in Public Companies.

– Updated preclinical data will be presented on CRISPR/Cas9-mediated targeted gene insertion to treat alpha-1 antitrypsin deficiency (AATD) CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), today announced the presentation of new data from its CRISPR/Cas9 platform at the 24th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, taking place virtually from May 11-14, 2021. “The data accepted for presentation at ASGCT reflects our ongoing commitment to finding new ways to treat and potentially cure a variety of diseases. Utilizing our modular in vivo insertion technology, we demonstrate the potential to durably restore normal AAT protein levels after a single dose. We continue to advance multiple genome editing strategies for patients living with AATD,” said President...

New Preclinical Data from Dyne Therapeutics’ Myotonic Dystrophy Type 1 Program to be Featured in Presentations During Upcoming American Society of Gene & Cell Therapy Annual Meeting

Written by Customer Service on April 27, 2021. Posted in Public Companies.

WALTHAM, Mass., April 27, 2021 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that new preclinical data from its myotonic dystrophy type 1 (DM1) program will be featured in presentations during the American Society of Gene & Cell Therapy (ASGCT) 24th Annual Meeting, to be held virtually May 11-14, 2021. ASGCT abstracts are available on the meeting website, and Dyne’s presentations are noted below. Presentation: Splice Correction and Reduction of Toxic DMPK RNA In Vitro and In Vivo Utilizing Novel Antibody Targeted Antisense OligonucleotidesScientific Symposium: Hot Topics and Remaining Challenges in RNAi and Oligonucleotide Therapy for 2021Date/Time: Friday, May...

Freeline to Present Data at the American Society of Gene and Cell Therapy Annual Meeting 2021

Written by Customer Service on April 27, 2021. Posted in Public Companies.

LONDON, April 27, 2021 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative gene therapies for patients suffering from inherited systemic debilitating diseases, today announced that the Company will give six poster presentations at the American Society of Gene and Cell Therapy Annual Meeting 2021, taking place May 11 – 14. “We are excited to be presenting six posters at the upcoming ASGCT conference, which together highlight the scientific foundation that underlies our gene therapy programs and broader platform technology,” said Theresa Heggie, CEO of Freeline. “These posters are reflective of steady progress at Freeline, which we expect will include three gene therapies in the clinic by year end.” Poster Presentation...

Fate Therapeutics Announces Four Presentations at the 2021 ASGCT Annual Meeting

Written by Customer Service on April 27, 2021. Posted in Public Companies.

Two Oral Presentations to Cover iPSC-derived Cell-based Cancer Immunotherapy Pipeline Company to Host Investor Event on May 13 to Highlight Interim Phase 1 Clinical Data from the Company’s FT516 and FT538 Programs for Relapsed / Refractory AML SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that two oral and two digital presentations of the Company’s induced pluripotent stem cell (iPSC) product platform were accepted for presentation at the 24th American Society of Gene & Cell Therapy Annual Meeting (ASGCT) being held virtually from May 11-14, 2021. In addition to the Company’s presentations at ASGCT, its iPSC-derived natural killer (NK)...

LeMaitre to Present at Upcoming Investor Conferences

Written by Customer Service on April 27, 2021. Posted in Public Companies.

BURLINGTON, Mass., April 27, 2021 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in May. David Roberts, President, is scheduled to participate in the 7th Annual Truist Securities Life Sciences Summit on Tuesday, May 4, 2021. He is also scheduled to present at the UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021, at 9:00 AM EDT. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com. Contact:Sandra...

Artisan Partners Asset Management Inc. Reports 1Q21 Results

Written by Customer Service on April 27, 2021. Posted in Dividend Reports And Estimates.

MILWAUKEE, April 27, 2021 (GLOBE NEWSWIRE) — Artisan Partners Asset Management Inc. (NYSE: APAM) (the “Company” or “Artisan Partners”) today reported its results for the three months ended March 31, 2021, and declared a quarterly dividend. The full March 2021 quarter earnings release and investor presentation can be viewed at www.apam.com. Conference Call The Company will host a conference call on April 28, 2021 at 1:00 p.m. (Eastern Time) to discuss these results. Hosting the call will be Eric Colson, Chairman and Chief Executive Officer, and C.J. Daley, Chief Financial Officer. Supplemental materials that will be reviewed during the call are available on the Company’s website at www.apam.com. The call will be webcast and can be accessed via the Company’s website. Listeners may also access the call by dialing 877.328.5507 or 412.317.5423...

Lydall Announces First Quarter 2021 Results; Strong Demand Across the Business Drives Healthy Margin Expansion

Written by Customer Service on April 27, 2021. Posted in Earnings Releases And Operating Results.

FINANCIAL HIGHLIGHTS* – Q1 2021Net sales of $227.1 million, up 13.3% compared to prior year on strong demand across all three segments; up 10.8% organically Gross margin and adjusted gross margin of 21.4%, up 220 bps Net income of $5.1 million or $0.28 per diluted share compared to loss per share of ($3.25) in Q1-2020; Adjusted earnings per diluted share of $0.35 compared to adjusted earnings per diluted share of $0.20 EBITDA of $22.7 million or 10.0% of sales; Adjusted EBITDA up 22.0% to $24.4 million, or 10.7% of sales Total debt net of cash of $172.3 million, compared to $200.3 million at March 31, 2020; net debt leverage ratio of 2.4x*Reconciliations of the Non-GAAP financial measures to Lydall’s GAAP financial results are included at the end of this release. See also “Use of Non-GAAP Financial Measures” below. MANCHESTER,...

Retail Opportunity Investments Corp. Reports 2021 First Quarter Results

Written by Customer Service on April 27, 2021. Posted in Earnings Releases And Operating Results.

SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) — Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today financial and operating results for the three months ended March 31, 2021. HIGHLIGHTS$7.4 million of net income attributable to common stockholders ($0.06 per diluted share) $31.0 million in Funds From Operations(1)($0.24 per diluted share) 91.8% of total 1Q’21 billed base rent has been paid through 4/22/21 92.7% of April billed base rent has been paid through 4/26/21 96.9% portfolio lease rate at March 31, 2021 (positive net absorption since 12/31/20) 99.2% of total tenants are currently open, based on annualized base rent 293,441 square feet of leases executed (on par with pre-pandemic first quarter activity) 4.9% increase in same-space cash rents on new leases (3.2% increase on renewals) 5.6% decrease in same-center...

American Assets Trust, Inc. Reports First Quarter 2021 Financial Results and COVID-19 Operational Update

Written by Customer Service on April 27, 2021. Posted in Earnings Releases And Operating Results.

Net income available to common stockholders of $1.3 million for the first quarter, or $0.02 per diluted share Funds From Operations per diluted share decreased 32% year-over-year for the first quarter, to $0.38 per diluted share Collected 93% to date of rents that were due during the first quarter of 2021 SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) — American Assets Trust, Inc. (NYSE: AAT) (the “company”) today reported financial results for its first quarter ended March 31, 2021. First Quarter HighlightsNet income available to common stockholders of $1.3 million for the first quarter, or $0.02 per diluted share. Funds From Operations decreased 32% year-over-year to $0.38 per diluted share for the first quarter. Same-store cash NOI decreased 4.5% year-over-year for the first quarter. Excluding lease termination fees, same-store...

Meta Financial Group, Inc.® Announces Results for 2021 Fiscal Second Quarter

Written by Customer Service on April 27, 2021. Posted in Earnings Releases And Operating Results.

SIOUX FALLS, S.D., April 27, 2021 (GLOBE NEWSWIRE) — Meta Financial Group, Inc.® (Nasdaq: CASH) (“Meta” or the “Company”) reported net income of $59.1 million, or $1.84 per share, for the three months ended March 31, 2021, compared to net income of $52.3 million, or $1.45 per share, for the three months ended March 31, 2020. “Our Tax Services and Payments businesses and the increased interest income from our Commercial Finance business combined to produce solid second quarter revenue results,” said President and CEO Brad Hanson. “We continued to develop our Banking as a Service franchise, including the launch of a new partnership with Walgreens. During the quarter, we distributed cards for the second and third rounds of Economic Impact Payments and further developed our Environmental, Social and Governance efforts, all of which...

Day: April 27, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals